SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-21-102162
Filing Date
2021-08-09
Accepted
2021-08-09 16:27:03
Documents
4
Group Members
AEQUANIMITAS LIMITED PARTNERSHIPSOUTH CONE INVESTMENTS LIMITED PARTNERSHIPSOUTH LAKE ONE LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D tm2124473d1_sc13d.htm SC 13D 91775
2 EXHIBIT 99.1 tm2124473d1_ex99-1.htm EX-99.1 29964
3 EXHIBIT 99.2 tm2124473d1_ex99-2.htm EX-99.2 30432
4 EXHIBIT 99.3 tm2124473d1_ex99-3.htm EX-99.3 10554
  Complete submission text file 0001104659-21-102162.txt   164229
Mailing Address VENIDA PRESIDENTE RIESCO 5711 OFICINA 16 LAS CONDES SANTIAGO F3 7550000
Business Address
Quiroga Moreno Isidoro (Filed by) CIK: 0001794307 (see all company filings)

Type: SC 13D

Mailing Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address 2051 RINGWOOD AVENUE SAN JOSE CA 95131 (408) 457-3700
Rani Therapeutics Holdings, Inc. (Subject) CIK: 0001856725 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92761 | Film No.: 211156872
SIC: 2834 Pharmaceutical Preparations